Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 3, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Tenoxicam

Intra-articular administration of tenoxicam, 20 milligrams as a single injection, delivered through an anterolateral approach under aseptic technique.

DRUG

Triamcinolone Acetonide

Intra-articular administration of triamcinolone acetonide, 40 milligrams as a single injection, delivered through an anterolateral approach under aseptic technique.

Trial Locations (1)

13511

Benha University Hospitals, Department of Orthopedics and Rheumatology, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT07194135 - Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management | Biotech Hunter | Biotech Hunter